US Minimally Invasive Surgery Market Size to Exceed USD 16.01 Billion by 2034

The US minimally invasive surgery market size surpassed USD 10.9 billion in 2024 and is predicted to reach around USD 16.01 billion by 2034, registering a CAGR of 3.91% from 2025 to 2034.

Highlights of the US Minimally Invasive Surgery Market

• By application, the orthopedic segment held a dominant presence in the market in 2024.
• By application, the cardiac surgery segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By device, the handheld instruments segment accounted for a considerable share of the market in 2024.
• By device, the electrosurgical segment is projected to experience the highest growth rate in the market between 2025 and 2034.
• By end use, the hospital segment led the market.
• By end use, the ambulatory surgical centers segment is set to experience the fastest rate of market growth from 2025 to 2034.

Industry Valuation and Growth Rate Projection

The U.S. market for minimally invasive surgery is expanding significantly because people want safer and faster surgery. Minimally invasive surgery involves using small incisions, tiny tools, and cameras to do surgery, which makes incision size, pain, recovery time, and hospital stay shorter. Physicians have been using minimally invasive surgery for many surgeries, including heart surgery, stomach surgery, and joint surgery.

A growing number of physicians now perform minimally invasive surgery with new technologies for minimally invasive surgery, like robotic surgery and greater imaging. Because many clinics and hospitals favor this type of surgery, there is a growing demand for this type of surgery. The growing population of elderly people who often require surgery is also favoring this option. The U.S. market for minimally invasive surgery is expected to grow significantly.

What are the Market Trends in the US Minimally Invasive Surgery Market?

The market trends in the U.S. minimally invasive surgery market indicate a rise in robotic-assisted surgeries, increased usage of laparoscopy and endoscopy, increased demand for outpatient surgery, and increased interest in cosmetic and weight-loss procedures.

• Hospitals in the U.S. are utilizing robots such as the da Vinci robot due to their increased accuracy and faster recovery times.
• Laparoscopic and endoscopic instruments are quickly becoming the most popular tools for performing small-cut surgery in the U.S.
• More Americans are electing to have surgery done the same day in surgery outpatient centers, so they do not have to stay at a hospital, and they save money.
• There is an increase in interest in bariatric (weight-loss) and minimally invasive cosmetic surgical procedures in the U.S.

What are the Restraints in the US Minimally Invasive Surgery Market?

Restraints in the U.S. minimally invasive surgery market include High costs of surgical devices, a lack of surgeons trained for new minimally invasive procedures, and increased potential for surgical errors in difficult cases.

• There is a high market price for advanced and robotic devices, making it difficult for small hospitals to afford them.
• Not every U.S. physician is trained and skilled in minimally invasive techniques, limiting access to these procedures.
• For some complex surgeries, employing small tools can create an increase in surgical error potential or time to completion of the surgery.

What are the Opportunities in the US Minimally Invasive Surgery Market?

Growth opportunities in the U.S. minimally invasive surgery market are linked to the aging population in the U.S., robust government support for advanced health care, and growing patient volumes for outpatient and ambulatory surgery centers.

• Older adults regularly necessitate surgery, both minor and serious in scope, and tend to prefer methods that lessen recovery time, including minimally invasive techniques.
• The U.S. is also no stranger to sizable amounts of health programming and funding that allow hospitals to utilize advanced surgical technologies.
• Outpatient and ambulatory surgery centers are multiplying at enormous rates and creating more options for patients to undergo minimally invasive surgery.

Recent Developments in the US Minimally Invasive Surgery Market:

• In June 2025, Yale Medicine began a new treatment for Normal Pressure Hydrocephalus (NPH), providing better diagnosis through spinal taps and imaging. Patients have stated they are now able to walk better and have improved their memory after their shunt surgeries, which has led some physicians to believe that we may be able to start treatment on patients sooner and with a more accurate diagnosis.
• In June 2025, for the first time in history, a surgeon in the U.S. performed remote robotic surgery on a patient in Africa using 5G and robotic technology. This operation documented a breakthrough moment in healthcare access.
• In February 2025, AdventHealth Ocala received the 2025 Women's Choice Award® as one of America's best hospitals for minimally invasive surgery. In addition to the award, the survey and announcement indicated excellence, patient safety, lower complication rates, and a commitment to women's advanced surgical care.